Targeting Free Prostate-Specific Antigen forIn VivoImaging of Prostate Cancer Using a Monoclonal Antibody Specific for Unique Epitopes Accessible on Free Prostate-Specific Antigen Alone

Cancer Biotherapy and Radiopharmaceuticals - United States
doi 10.1089/cbr.2011.1088
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Stability of Total Prostate-Specific Antigen and Free Prostate-Specific Antigen After 10 Years’ Storage

International Journal of Biological Markers
OncologyCancer ResearchClinical BiochemistryForensic MedicineMedicinePathology
2018English

Effects of Hemodialysis on Free/Total Prostate Specific Antigen.

Nihon Toseki Igakkai Zasshi
1999English

Targeting Novel Antigens for Prostate Cancer Treatment: Focus on Prostate-Specific Membrane Antigen

Expert Opinion on Therapeutic Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2005English

Percent Free Prostate-Specific Antigen: Entering a New Era in the Detection of Prostate Cancer

Mayo Clinic Proceedings
Medicine
1997English

PET Imaging of Prostate Cancer Xenografts With a Highly Specific Antibody Against the Prostate-Specific Membrane Antigen

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2009English

Prostate-Specific Membrane Antigen Based Antibody-Drug Conjugates for Metastatic Castration-Resistance Prostate Cancer

Cureus
2020English

Recommendations on Screening for Prostate Cancer With the Prostate-Specific Antigen Test

CMAJ
Medicine
2014English

The Role of Prostate-Specific Antigen in Prostate Cancer Screening

Romanian Review of Laboratory Medicine
2014English

Prostate-Specific Membrane Antigen–directed Nanoparticle Targeting for Extreme Nearfield Ablation of Prostate Cancer Cells

Tumor Biology
MedicineCancer Research
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy